Ingels, Aude
Scott, Robert
Hooper, Annie R.
van der Westhuyzen, Aletta E.
Wagh, Sachin B.
de Meester, Joséphine
Maddau, Lucia
Marko, Doris
Aichinger, Georg
Berger, Walter
Vermeersch, Marjorie
Pérez-Morga, David
Maslivetc, Vladimir A.
Evidente, Antonio
van Otterlo, Willem A. L.
Kornienko, Alexander
Mathieu, Véronique
Funding for this research was provided by:
Gouvernement Wallon
National Research Foundation (UID 113322)
Universiteit Stellenbosch
Foundation for the National Institutes of Health (GM131717-01)
Belgian Brain Tumor Support
Article History
Received: 19 April 2024
Accepted: 19 June 2024
First Online: 25 June 2024
Competing interests
: A.K., V.M., W.A.L.v.O, A.E., A.I. and S.B.W. are inventors of the patent application PCT/US23/35648 (date of application 21 October 2023). The novel chemical entities and their mode of action described in the paper are part of the patent application. Remaining Authors have no competing interests.